RTW Biotech Opportunities (LSE:RTW) Cash per Share: $0.02 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
40 GF Score
Price $2.58
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities Cash per Share?

RTW Biotech Opportunities LSE:RTW -1.15% 40 Cash per Share is $0.02 as of Dec. 2025. GuruFocus rates LSE:RTW with a GF Score™ of 40/100. The stock has 2 warning signs investors should review.

Cash per Share is calculated as Balance Sheet Cash And Cash Equivalents divided by Shares Outstanding (EOP). RTW Biotech Opportunities's Cash per Share for the quarter that ended in Dec. 2025 was $0.02.

RTW Biotech Opportunities  (LSE:RTW) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

RTW Biotech Opportunities Cash per Share Related Terms

RTW Biotech Opportunities Cash per Share Historical Data

* Premium members only.

The historical data trend for RTW Biotech Opportunities's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTW Biotech Opportunities Cash per Share Chart

RTW Biotech Opportunities Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial 0.03 0.03 0.01 0.02 0.02

RTW Biotech Opportunities Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.02 0.01 0.02
LSE:RTW
40GF Score
RTW Biotech Opportunities Ltd LSE:RTW
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

RTW Biotech Opportunities's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Balance Sheet Cash And Cash Equivalents /Shares Outstanding (EOP)
=5.986/326.4
=0.02

RTW Biotech Opportunities's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share= Balance Sheet Cash And Cash Equivalents /Shares Outstanding (EOP)
=5.986/326.4
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of $0.02 mean?
RTW Biotech Opportunities (LSE:RTW) has a Cash per Share of $0.02 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for RTW Biotech Opportunities and its competitors.
Is RTW Biotech Opportunities' Cash per Share too high?
RTW Biotech Opportunities' current Cash per Share is $0.02. Overall, RTW Biotech Opportunities has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does RTW Biotech Opportunities' Cash per Share compare to BLK and BX?
RTW Biotech Opportunities' Cash per Share of $0.02 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for an Asset Management company?
A good Cash per Share depends on the Asset Management industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for RTW Biotech Opportunities and its competitors. RTW Biotech Opportunities's current Cash per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RTW Biotech Opportunities stock overvalued right now?
RTW Biotech Opportunities (LSE:RTW) has a current Cash per Share of $0.02. The current Cash per Share is $0.02. RTW Biotech Opportunities' overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For RTW Biotech Opportunities (LSE:RTW), the current Cash per Share is $0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
40GF Score

Get the complete analysis for LSE:RTW

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.58
Price